On August 24, 2018, the Office of Controlled Substances (OCS), Health Canada granted Medipure Pharmaceuticals Inc. a full Level 6 Dealer's License for Controlled Substances pursuant to the Controlled Drugs and Substances Act.
Medipure Holdings Inc. has taken the next step to advance its research and development by creating a subsidiary, Medipure LifeSciences India (MLSI) Pvt Ltd.
